Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial

  1. Chan, A.
  2. Moy, B.
  3. Mansi, J.
  4. Ejlertsen, B.
  5. Holmes, F.A.
  6. Chia, S.
  7. Iwata, H.
  8. Gnant, M.
  9. Loibl, S.
  10. Barrios, C.H.
  11. Somali, I.
  12. Smichkoska, S.
  13. Martinez, N.
  14. Alonso, M.G.
  15. Link, J.S.
  16. Mayer, I.A.
  17. Cold, S.
  18. Murillo, S.M.
  19. Senecal, F.
  20. Inoue, K.
  21. Ruiz-Borrego, M.
  22. Hui, R.
  23. Denduluri, N.
  24. Patt, D.
  25. Rugo, H.S.
  26. Johnston, S.R.D.
  27. Bryce, R.
  28. Zhang, B.
  29. Xu, F.
  30. Wong, A.
  31. Martin, M.
  32. Show all authors +
Journal:
Clinical Breast Cancer

ISSN: 1938-0666,  1526-8209

Year of publication: 2021

Volume: 21

Issue: 1

Pages: 80-91.e7

Type: Article

DOI: 10.1016/J.CLBC.2020.09.014 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus